Addus HomeCare Co. (NASDAQ:ADUS) Short Interest Update

Addus HomeCare Co. (NASDAQ:ADUS) was the recipient of a large decrease in short interest during the month of October. As of October 15th, there was short interest totalling 486,600 shares, a decrease of 11.3% from the September 30th total of 548,700 shares. Based on an average trading volume of 125,700 shares, the days-to-cover ratio is currently 3.9 days.

Insiders Place Their Bets

In other Addus HomeCare news, Director Esteban Lopez sold 500 shares of the business’s stock in a transaction dated Wednesday, September 4th. The shares were sold at an average price of $130.03, for a total value of $65,015.00. Following the completion of the transaction, the director now directly owns 3,866 shares of the company’s stock, valued at approximately $502,695.98. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other news, Director Esteban Lopez sold 500 shares of Addus HomeCare stock in a transaction on Wednesday, September 4th. The stock was sold at an average price of $130.03, for a total value of $65,015.00. Following the completion of the sale, the director now directly owns 3,866 shares of the company’s stock, valued at approximately $502,695.98. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Michael D. Wattenbarger sold 21,917 shares of the business’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $133.29, for a total value of $2,921,316.93. Following the sale, the executive vice president now owns 7,215 shares of the company’s stock, valued at approximately $961,687.35. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 22,917 shares of company stock valued at $3,050,082 in the last 90 days. 4.60% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Addus HomeCare

Several institutional investors and hedge funds have recently modified their holdings of ADUS. Ellsworth Advisors LLC bought a new position in Addus HomeCare in the second quarter valued at approximately $598,000. Quadrature Capital Ltd bought a new stake in Addus HomeCare in the 1st quarter valued at $1,557,000. Lord Abbett & CO. LLC acquired a new position in Addus HomeCare in the 1st quarter worth $8,274,000. Vanguard Group Inc. increased its holdings in Addus HomeCare by 3.2% during the 4th quarter. Vanguard Group Inc. now owns 1,257,440 shares of the company’s stock worth $116,753,000 after purchasing an additional 38,876 shares in the last quarter. Finally, SG Americas Securities LLC acquired a new stake in shares of Addus HomeCare in the 2nd quarter valued at about $842,000. 95.35% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

ADUS has been the topic of several recent research reports. TD Cowen raised their target price on shares of Addus HomeCare from $128.00 to $137.00 and gave the company a “buy” rating in a research note on Thursday, August 8th. Oppenheimer raised their price objective on shares of Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a research note on Monday, September 23rd. Stephens reiterated an “overweight” rating and set a $138.00 target price on shares of Addus HomeCare in a research report on Tuesday, August 6th. Macquarie restated an “outperform” rating and issued a $139.00 price target on shares of Addus HomeCare in a research report on Friday, October 11th. Finally, StockNews.com cut Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research note on Sunday, July 7th. One investment analyst has rated the stock with a sell rating, eight have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $131.38.

Addus HomeCare Stock Down 3.2 %

Shares of ADUS stock opened at $125.69 on Thursday. Addus HomeCare has a 12-month low of $78.35 and a 12-month high of $136.12. The firm has a fifty day moving average of $130.46 and a 200-day moving average of $119.83. The firm has a market capitalization of $2.27 billion, a price-to-earnings ratio of 31.19, a price-to-earnings-growth ratio of 2.33 and a beta of 1.04.

Addus HomeCare (NASDAQ:ADUS) last posted its earnings results on Monday, August 5th. The company reported $1.35 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.21 by $0.14. The firm had revenue of $286.90 million during the quarter, compared to analysts’ expectations of $284.90 million. Addus HomeCare had a return on equity of 9.81% and a net margin of 6.18%. The company’s revenue was up 10.4% on a year-over-year basis. During the same period in the previous year, the firm earned $0.94 earnings per share. Research analysts expect that Addus HomeCare will post 4.58 earnings per share for the current year.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.